Clinical Trials Logo

Clinical Trial Summary

Depressive disorder, also known as depression, is a type of mood disorder characterized by persistent low mood. The incidence of depression worldwide is about 6%. The high comorbidity rate between depression and constipation indicated the role of the gut-brain axis in depression. Growing evidence suggested that the gut microbiota plays a key role in the development of depression. Probiotics can effectively improve constipation and regulate gut microbiota, and showed potential in alleviating depression. This study investigated the effect of formula probiotic (containing Lactobacillus paracasei, Bifidobacterium animals, Bifidobacterium longum, Bifidobacterium bifidum, and Lactobacillus plantarum) on the comorbidity of depression and constipation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04570072
Study type Interventional
Source China Agricultural University
Contact Fazheng Ren, PhD
Phone +86-10-62736344
Email renfazheng@cau.edu.cn
Status Not yet recruiting
Phase N/A
Start date November 1, 2020
Completion date December 30, 2021